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Atrial Fibrillation (AF) is associated with increased morbidity and mortality and 
a more severe impairment in quality of life compared with patients with congestive 
heart failure or myocardial infarction. Left atrial myocardial extensions, known as 
“myocardial sleeves”, are present in almost all pulmonary veins (PVs), and have been 
recognized as the main source of triggers that initiate and perpetuate AF. 
In this setting, electrical isolation of the PVs have been accepted as the basis of AF 
catheter ablation. Three-dimensional (3D) heart geometry is an innovative technique 
facilitating the AF ablation procedure. After a single transseptal puncture, the 3D 
geometry of the left atrium is reconstructed using the CARTO 3 navigation system 
(Biosense Webster, Inc., Diamond Bar, CA, USA). Wide circumferential lesions for 
isolation of large atrial areas around both ipsilateral PVs (PV antral isolation) are 
applied using a 3.5-mm-tip ablation catheter. Circumferential ablation is performed 
on the posterior wall >1 cm and on the anterior wall >5 mm away from the defined 
PV ostia. The end point of ablation is the absence or dissociation of potentials in the 
isolated area as documented with the circular mapping (“lasso”) catheter. When PV 
conduction is still present following wide circumferential lesions around both ipsilateral 
veins, both PVs are mapped sequentially by the circular mapping catheter to localize 
the earliest PV potentials. Based on the earliest PV potentials recorded by the circular 
mapping catheter, RF energy is reapplied to close the conduction gap.
By using this method of AF ablation, in our patients with paroxysmal AF, we have 
succeeded a 70% sinus rhythm maintenance during a short and medium term follow 
up. In a recently published paper by our electrophysiology laboratory team (Eu-
ropace 2014;16:202), 126 patients (78 males, median age 61 years) with symptomatic 
paroxysmal AF underwent left atrial ablation. Over 16 months (interquartile range: 
10.8–26.0), 89 patients were recurrence-free (70.6%). Larger left atrial volume (P: 
0.039), diabetes (P: 0.001), dyslipidemia (P: 0.003), coronary artery disease (P: 0.003), 
class III antiarrhythmic drugs (P: 0.017), CHADS2 (P: 0.006), and CHA2DS2-VASc (P: 
0.016) scores were univariately associated with recurrence. In the multivariate analysis, 
both CHADS2 (hazard ratio: 1.91, 95% confidence interval 1.09–3.36, P: 0.023) and 
CHA2DS2-VASc (hazard ratio: 1.97, 95% confidence interval 1.16–3.33, P: 0.012) 
were independently associated with AF recurrence. Cut-off analysis showed that a 
score ≥2 for both the CHADS2 (sensitivity = 46% and specificity = 79%, area under 
the Receiver’s operating characteristic curve, AUC = 0.644) and CHA2DS2-VASc 
score (sensitivity = 57% and specificity = 65%, AUC = 0.627) showed the highest 
predictive value for AF recurrence.
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AbbreviAtions
3D = three-dimensional
AF = atrial fibrillation 
PV = pulmonary vein
